132 related articles for article (PubMed ID: 22374530)
41. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
42. [Primary multifocal osseous Hodgkin lymphoma].
Oshikawa G; Arai A; Sasaki K; Ichinohasama R; Miura O
Rinsho Ketsueki; 2009 Feb; 50(2):92-6. PubMed ID: 19265301
[TBL] [Abstract][Full Text] [Related]
43. Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.
Dinand V; Sachdeva A; Datta S; Bhalla S; Kalra M; Wattal C; Radhakrishnan N
Indian Pediatr; 2015 Aug; 52(8):681-5. PubMed ID: 26388626
[TBL] [Abstract][Full Text] [Related]
44. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease.
Ito Y; Suzuki M; Kawada J; Kimura H
J Infect Chemother; 2016 Apr; 22(4):268-71. PubMed ID: 26712582
[TBL] [Abstract][Full Text] [Related]
46. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
[TBL] [Abstract][Full Text] [Related]
47. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
[TBL] [Abstract][Full Text] [Related]
48. Hodgkin lymphoma with cutaneous involvement.
Hsia CC; Howson-Jan K; Rizkalla KS
Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C
AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus-positive Hodgkin lymphoma-like earlobe lymphoid infiltrate: case report.
Tanese K; Haratoh R; Yamamoto K; Wakabayashi A; Irie R; Miyakawa S
Am J Dermatopathol; 2009 Dec; 31(8):838-45. PubMed ID: 19770629
[TBL] [Abstract][Full Text] [Related]
51. [Hodgkin lymphoma of the nasopharynx associated with a pituitary adenoma].
Takashima H; Kawashima K; Isayama Y
Rinsho Ketsueki; 2003 Dec; 44(12):1172-4. PubMed ID: 14978934
[TBL] [Abstract][Full Text] [Related]
52. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings.
Kamper PM; Kjeldsen E; Clausen N; Bendix K; Hamilton-Dutoit S; d'Amore F
Br J Haematol; 2005 Jun; 129(5):615-7. PubMed ID: 15916683
[TBL] [Abstract][Full Text] [Related]
55. Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.
Gulley ML; Fan H; Elmore SH
J Mol Diagn; 2006 Nov; 8(5):589-97. PubMed ID: 17065428
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
[TBL] [Abstract][Full Text] [Related]
57. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells.
Wagner HJ; Jabs W; Smets F; Wessel M; Fischer L; Offner G; Kirchner H; Bucsky P
Klin Padiatr; 2000; 212(4):206-10. PubMed ID: 10994552
[TBL] [Abstract][Full Text] [Related]
58. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
[TBL] [Abstract][Full Text] [Related]
59. [A Case of Severe Chronic Active Epstein-Barr Virus Infection with Aplastic Anemia and Hepatitis].
Lee JI; Lee SW; Han NI; Ro SM; Noh YS; Jang JW; Bae SH; Choi JY; Yoon SK
Korean J Gastroenterol; 2016 Jan; 67(1):39-43. PubMed ID: 26809631
[TBL] [Abstract][Full Text] [Related]
60. Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.
Wang WY; Twu CW; Lin WY; Jiang RS; Liang KL; Chen KW; Wu CT; Shih YT; Lin JC
Cancer; 2011 Oct; 117(19):4452-9. PubMed ID: 21437892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
